Catalyst Wire Dossier Catalyst Wire Dossier

altSonflex1-2-3 vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for altSonflex1-2-3 vaccine, covering 2025-12-04 to 2026-06-22. Get the full timeline:

Most recent: Clinical Trial Results: A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants [Phase 1, Phase 2]

See pricing